Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.
Identifieur interne : 000042 ( Main/Exploration ); précédent : 000041; suivant : 000043Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.
Auteurs : Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne]Source :
- Revista espanola de cardiologia (English ed.) [ 1885-5857 ] ; 2021.
Descripteurs français
- KwdFr :
- Antibactériens (effets indésirables), Antibactériens (usage thérapeutique), Antipaludiques (effets indésirables), Antipaludiques (usage thérapeutique), Association de médicaments (MeSH), Azithromycine (effets indésirables), Azithromycine (usage thérapeutique), Femelle (MeSH), Humains (MeSH), Hydroxychloroquine (effets indésirables), Hydroxychloroquine (usage thérapeutique), Sujet âgé (MeSH), Syndrome du QT long (diagnostic), Syndrome du QT long (induit chimiquement), Syndrome du QT long (physiopathologie), Électrocardiographie (effets des médicaments et des substances chimiques), Électrocardiographie (méthodes).
- MESH :
- diagnostic : Syndrome du QT long.
- effets des médicaments et des substances chimiques : Électrocardiographie.
- effets indésirables : Antibactériens, Antipaludiques, Azithromycine, Hydroxychloroquine.
- induit chimiquement : Syndrome du QT long.
- méthodes : Électrocardiographie.
- physiopathologie : Syndrome du QT long.
- usage thérapeutique : Antibactériens, Antipaludiques, Azithromycine, Hydroxychloroquine.
- Association de médicaments, Femelle, Humains, Sujet âgé.
English descriptors
- KwdEn :
- Aged (MeSH), Anti-Bacterial Agents (adverse effects), Anti-Bacterial Agents (therapeutic use), Antimalarials (adverse effects), Antimalarials (therapeutic use), Azithromycin (adverse effects), Azithromycin (therapeutic use), COVID-19 (drug therapy), COVID-19 (epidemiology), Drug Therapy, Combination (MeSH), Electrocardiography (drug effects), Electrocardiography (methods), Female (MeSH), Humans (MeSH), Hydroxychloroquine (adverse effects), Hydroxychloroquine (therapeutic use), Long QT Syndrome (chemically induced), Long QT Syndrome (diagnosis), Long QT Syndrome (physiopathology), SARS-CoV-2 (MeSH).
- MESH :
- chemical , adverse effects : Anti-Bacterial Agents, Antimalarials, Azithromycin, Hydroxychloroquine.
- chemical , therapeutic use : Anti-Bacterial Agents, Antimalarials, Azithromycin, Hydroxychloroquine.
- chemically induced : Long QT Syndrome.
- diagnosis : Long QT Syndrome.
- drug effects : Electrocardiography.
- drug therapy : COVID-19.
- epidemiology : COVID-19.
- methods : Electrocardiography.
- physiopathology : Long QT Syndrome.
- Aged, Drug Therapy, Combination, Female, Humans, SARS-CoV-2.
DOI: 10.1016/j.rec.2020.08.020
PubMed: 33077410
PubMed Central: PMC7528841
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.</title>
<author><name sortKey="Garcia Fernandez, Amaya" sort="Garcia Fernandez, Amaya" uniqKey="Garcia Fernandez A" first="Amaya" last="García-Fernández">Amaya García-Fernández</name>
<affiliation wicri:level="1"><nlm:affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain. Electronic address: ama_garcia@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ramos Ruiz, Pablo" sort="Ramos Ruiz, Pablo" uniqKey="Ramos Ruiz P" first="Pablo" last="Ramos-Ruiz">Pablo Ramos-Ruiz</name>
<affiliation wicri:level="1"><nlm:affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Iba Ez Criado, Alicia" sort="Iba Ez Criado, Alicia" uniqKey="Iba Ez Criado A" first="Alicia" last="Ibá Ez-Criado">Alicia Ibá Ez-Criado</name>
<affiliation wicri:level="1"><nlm:affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Moreno Perez, Scar" sort="Moreno Perez, Scar" uniqKey="Moreno Perez " first=" Scar" last="Moreno-Pérez"> Scar Moreno-Pérez</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Endocrinología y Nutrición, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, Elche, Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departamento de Endocrinología y Nutrición, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, Elche, Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cambra Poveda, Cristina" sort="Cambra Poveda, Cristina" uniqKey="Cambra Poveda C" first="Cristina" last="Cambra-Poveda">Cristina Cambra-Poveda</name>
<affiliation wicri:level="1"><nlm:affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Martinez Martinez, Juan Gabriel" sort="Martinez Martinez, Juan Gabriel" uniqKey="Martinez Martinez J" first="Juan Gabriel" last="Martínez-Martínez">Juan Gabriel Martínez-Martínez</name>
<affiliation wicri:level="1"><nlm:affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33077410</idno>
<idno type="pmid">33077410</idno>
<idno type="doi">10.1016/j.rec.2020.08.020</idno>
<idno type="pmc">PMC7528841</idno>
<idno type="wicri:Area/Main/Corpus">000994</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000994</idno>
<idno type="wicri:Area/Main/Curation">000994</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000994</idno>
<idno type="wicri:Area/Main/Exploration">000994</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.</title>
<author><name sortKey="Garcia Fernandez, Amaya" sort="Garcia Fernandez, Amaya" uniqKey="Garcia Fernandez A" first="Amaya" last="García-Fernández">Amaya García-Fernández</name>
<affiliation wicri:level="1"><nlm:affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain. Electronic address: ama_garcia@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ramos Ruiz, Pablo" sort="Ramos Ruiz, Pablo" uniqKey="Ramos Ruiz P" first="Pablo" last="Ramos-Ruiz">Pablo Ramos-Ruiz</name>
<affiliation wicri:level="1"><nlm:affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Iba Ez Criado, Alicia" sort="Iba Ez Criado, Alicia" uniqKey="Iba Ez Criado A" first="Alicia" last="Ibá Ez-Criado">Alicia Ibá Ez-Criado</name>
<affiliation wicri:level="1"><nlm:affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Moreno Perez, Scar" sort="Moreno Perez, Scar" uniqKey="Moreno Perez " first=" Scar" last="Moreno-Pérez"> Scar Moreno-Pérez</name>
<affiliation wicri:level="1"><nlm:affiliation>Departamento de Endocrinología y Nutrición, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, Elche, Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departamento de Endocrinología y Nutrición, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, Elche, Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cambra Poveda, Cristina" sort="Cambra Poveda, Cristina" uniqKey="Cambra Poveda C" first="Cristina" last="Cambra-Poveda">Cristina Cambra-Poveda</name>
<affiliation wicri:level="1"><nlm:affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Martinez Martinez, Juan Gabriel" sort="Martinez Martinez, Juan Gabriel" uniqKey="Martinez Martinez J" first="Juan Gabriel" last="Martínez-Martínez">Juan Gabriel Martínez-Martínez</name>
<affiliation wicri:level="1"><nlm:affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante</wicri:regionArea>
<wicri:noRegion>Alicante</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Revista espanola de cardiologia (English ed.)</title>
<idno type="eISSN">1885-5857</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term>
<term>Anti-Bacterial Agents (adverse effects)</term>
<term>Anti-Bacterial Agents (therapeutic use)</term>
<term>Antimalarials (adverse effects)</term>
<term>Antimalarials (therapeutic use)</term>
<term>Azithromycin (adverse effects)</term>
<term>Azithromycin (therapeutic use)</term>
<term>COVID-19 (drug therapy)</term>
<term>COVID-19 (epidemiology)</term>
<term>Drug Therapy, Combination (MeSH)</term>
<term>Electrocardiography (drug effects)</term>
<term>Electrocardiography (methods)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (adverse effects)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Long QT Syndrome (chemically induced)</term>
<term>Long QT Syndrome (diagnosis)</term>
<term>Long QT Syndrome (physiopathology)</term>
<term>SARS-CoV-2 (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antibactériens (effets indésirables)</term>
<term>Antibactériens (usage thérapeutique)</term>
<term>Antipaludiques (effets indésirables)</term>
<term>Antipaludiques (usage thérapeutique)</term>
<term>Association de médicaments (MeSH)</term>
<term>Azithromycine (effets indésirables)</term>
<term>Azithromycine (usage thérapeutique)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Hydroxychloroquine (effets indésirables)</term>
<term>Hydroxychloroquine (usage thérapeutique)</term>
<term>Sujet âgé (MeSH)</term>
<term>Syndrome du QT long (diagnostic)</term>
<term>Syndrome du QT long (induit chimiquement)</term>
<term>Syndrome du QT long (physiopathologie)</term>
<term>Électrocardiographie (effets des médicaments et des substances chimiques)</term>
<term>Électrocardiographie (méthodes)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Antimalarials</term>
<term>Azithromycin</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Antimalarials</term>
<term>Azithromycin</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Long QT Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Long QT Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome du QT long</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Electrocardiography</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Électrocardiographie</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antibactériens</term>
<term>Antipaludiques</term>
<term>Azithromycine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Syndrome du QT long</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Electrocardiography</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Électrocardiographie</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Syndrome du QT long</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Long QT Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antibactériens</term>
<term>Antipaludiques</term>
<term>Azithromycine</term>
<term>Hydroxychloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Drug Therapy, Combination</term>
<term>Female</term>
<term>Humans</term>
<term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association de médicaments</term>
<term>Femelle</term>
<term>Humains</term>
<term>Sujet âgé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33077410</PMID>
<DateCompleted><Year>2021</Year>
<Month>01</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1885-5857</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>74</Volume>
<Issue>1</Issue>
<PubDate><Year>2021</Year>
<Month>01</Month>
</PubDate>
</JournalIssue>
<Title>Revista espanola de cardiologia (English ed.)</Title>
<ISOAbbreviation>Rev Esp Cardiol (Engl Ed)</ISOAbbreviation>
</Journal>
<ArticleTitle>Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.</ArticleTitle>
<Pagination><MedlinePgn>108-111</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1885-5857(20)30428-X</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rec.2020.08.020</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>García-Fernández</LastName>
<ForeName>Amaya</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain. Electronic address: ama_garcia@hotmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ramos-Ruiz</LastName>
<ForeName>Pablo</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ibáñez-Criado</LastName>
<ForeName>Alicia</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Moreno-Pérez</LastName>
<ForeName>Óscar</ForeName>
<Initials>Ó</Initials>
<AffiliationInfo><Affiliation>Departamento de Endocrinología y Nutrición, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain; Departamento de Medicina Clínica, Universidad Miguel Hernández, Elche, Alicante, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Cambra-Poveda</LastName>
<ForeName>Cristina</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Martínez-Martínez</LastName>
<ForeName>Juan Gabriel</ForeName>
<Initials>JG</Initials>
<AffiliationInfo><Affiliation>Unidad de Arritmias, Servicio de Cardiología, Hospital General Universitario de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Alicante, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><CollectiveName>Research Investigation COVID-19 Alicante</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<Language>spa</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>10</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Spain</Country>
<MedlineTA>Rev Esp Cardiol (Engl Ed)</MedlineTA>
<NlmUniqueID>101587954</NlmUniqueID>
<ISSNLinking>1885-5857</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004562" MajorTopicYN="N">Electrocardiography</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008133" MajorTopicYN="N">Long QT Syndrome</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>07</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>08</Month>
<Day>25</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>10</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>1</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>10</Month>
<Day>20</Day>
<Hour>5</Hour>
<Minute>46</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33077410</ArticleId>
<ArticleId IdType="pii">S1885-5857(20)30428-X</ArticleId>
<ArticleId IdType="doi">10.1016/j.rec.2020.08.020</ArticleId>
<ArticleId IdType="pmc">PMC7528841</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Mayo Clin Proc. 2020 Jun;95(6):1213-1221</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32359771</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Heart Rhythm. 2020 Sep;17(9):1472-1479</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32438018</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Rev Esp Cardiol. 2020 Sep;73(9):771-773</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32834365</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Espagne</li>
</country>
</list>
<tree><country name="Espagne"><noRegion><name sortKey="Garcia Fernandez, Amaya" sort="Garcia Fernandez, Amaya" uniqKey="Garcia Fernandez A" first="Amaya" last="García-Fernández">Amaya García-Fernández</name>
</noRegion>
<name sortKey="Cambra Poveda, Cristina" sort="Cambra Poveda, Cristina" uniqKey="Cambra Poveda C" first="Cristina" last="Cambra-Poveda">Cristina Cambra-Poveda</name>
<name sortKey="Iba Ez Criado, Alicia" sort="Iba Ez Criado, Alicia" uniqKey="Iba Ez Criado A" first="Alicia" last="Ibá Ez-Criado">Alicia Ibá Ez-Criado</name>
<name sortKey="Martinez Martinez, Juan Gabriel" sort="Martinez Martinez, Juan Gabriel" uniqKey="Martinez Martinez J" first="Juan Gabriel" last="Martínez-Martínez">Juan Gabriel Martínez-Martínez</name>
<name sortKey="Moreno Perez, Scar" sort="Moreno Perez, Scar" uniqKey="Moreno Perez " first=" Scar" last="Moreno-Pérez"> Scar Moreno-Pérez</name>
<name sortKey="Ramos Ruiz, Pablo" sort="Ramos Ruiz, Pablo" uniqKey="Ramos Ruiz P" first="Pablo" last="Ramos-Ruiz">Pablo Ramos-Ruiz</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000042 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000042 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:33077410 |texte= Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33077410" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
This area was generated with Dilib version V0.6.38. |